We have identified the herpes simplex virus type 2 (HSV-2) UL55 gene product using a rabbit polyclonal antiserum raised against a recombinant 6iHis-UL55 fusion protein expressed in Escherichia coli. The antiserum reacted specifically with a 23 kDa protein in HSV-2 186-infected cell lysates. The protein was not detectable in the presence of the viral DNA synthesis inhibitor phosphonoacetic acid. Indirect immunofluorescence studies localized the UL55 protein within and at the periphery of the nucleus as discrete granules at late
Introduction
The genome of herpes simplex virus type 1 (HSV-1) comprises about 152 000 bp of double-stranded DNA and encodes at least 84 genes. Recent studies have shown that approximately half the genes are not essential for replication of the virus in cell culture (Roizman & Sears, 1996) . These dispensable gene products, however, are thought to be important for virus growth and spread in the natural host.
The focus of this report is on the product of the UL55 gene of HSV-2. This gene is predicted to encode a 186-amino-acid protein with a molecular mass of 20 kDa (McGeoch et al., 1991) and homologues of the UL55 protein are encoded only among alphaherpesviruses ; HSV-1 (McGeoch et al., 1988) , varicella-zoster virus (VZV) (Davison & Scott, 1986 ) and equine herpesvirus type 1 (EHV-1) (Telford et al., 1992) . It has been reported that open reading frames (ORFs) UL55 and UL56 of HSV-1 are not required for virus replication (Nash & Spivack, 1994) , and that the UL56 protein of HSV-1 is localized in the cytoplasm and can be detected in virions (Kehm et al., 1994) . It has also been reported that the AT1 plasmid, which possesses an unidentified ORF, α27, UL55 and UL56 inhibits stable DNA-mediated transformation and expression from the Author for correspondence : Yukihiro Nishiyama.
Fax j81 52 744 2452. e-mail ynishiya!tsuru.med.nagoya-u.ac.jp times post-infection, and nuclear fractionation studies showed that the protein was associated with the nuclear matrix of infected cells. Moreover, these discrete regions containing the UL55 protein were found to be adjacent to compartments, designated assemblons, containing the capsid protein ICP35. However, the UL55 protein was not detected in purified virions. These results suggest that the UL55 protein of HSV-2 may play an accessory role in virion assembly or maturation. chloramphenicol acetyltransferase gene under the control of either the HSV-1 tk gene or the Rous sarcoma virus promoter (Block et al., 1991) . Moreover, Harty et al. (1993) have shown that the UL2 gene of EHV-1, a homologue of HSV UL55, is maintained in the genome of defective interfering particles (DIPs), which mediate persistent infection. The UL2 protein is more abundant in DIP-infected cells than in standard EHV-1-infected cells, and the protein has a rapid turnover rate in DIPinfected cells. To our knowledge, however, there is no report on the identification and characterization of the UL55 gene product of HSV.
In this study, we made rabbit polyclonal antisera specific for the UL55 gene product of HSV-2 and examined its expression and properties. We found that the UL55 protein was associated with the nuclear matrix in infected cells, but was not detectable in purified virions. These properties of the UL55 protein are similar to those of the UL31 protein (Chang & Roizman, 1993 ; Blaho et al., 1994) , so we characterized the UL55 protein in comparison with the UL31 protein.
strain KOS and HSV-2 strain 186, and the HSV-1 variant HF, which has been reported to have a 4 kbp deletion in the BamHI B fragment of the HSV-1 genome, were used in this study (Jiang et al., 1995 ; Umene et al., 1984) . Viruses were propagated and titrated on Vero cells. Vero cells were infected at preconfluence with a multiplicity of 3 p.f.u. per cell.
Antibodies. The rabbit polyclonal antiserum to the UL16 protein has been described by Oshima et al. (1998) . Monoclonal antibody to the capsid protein ICP35 1102-1 was purchased from the Goodwin Institute for Cancer Research (Florida).
DNA manipulation. The UL55 ORF is located at the right end of the unique long region of the HSV-2 genome (McGeoch et al., 1991) . UL55 coding sequences were cloned by PCR amplification from HSV-2 186 genomic DNA, using synthetic oligonucleotide UL55N (GAA CAT ATG ACA ACG ACG CCC CTC TCG) as the forward primer and synthetic oligonucleotide UL55C (CCT CTC GAG GTT GCA TAC GGA CTC GGA) as the reverse primer. NdeI and XhoI sites were incorporated into the forward and reverse primers respectively to facilitate cloning. Similarly, UL31 coding sequences were cloned by PCR amplification from HSV-1 KOS genomic DNA (McGeoch et al., 1988) , using synthetic oligonucleotide UL31N (AAA GAA TTC ATG AGC CAG ACC CAA CCC CCG) as the forward primer and synthetic oligonucleotide UL31C (TTA GTC GAC TAC GGC GGA GGA AAC TCG TC) as the reverse primer. EcoRI and SalI sites were incorporated into the forward and reverse primers respectively. PCR amplification was carried out as described previously (Yamada et al., 1997) . PCR products were digested with NdeI and XhoI or EcoRI and SalI, respectively, and cloned in-frame into the downstream of the region encoding the initiating ATG plus six histidine residues in an Escherichia coli expression vector (pET-28a ; Novagen) to give plasmid pET28-UL55 or pET28-UL31. Resulting clones express UL55 and UL31 proteins with a 6iHis tag attached to the N terminus. Expression of these fusion proteins is regulated by an IPTG-inducible lac operator sequence and a phage T7 promoter. Translation is expected to terminate at the stop codon. These plasmid were transformed into E. coli strain BL21(DE3) (Novagen) which, following induction with IPTG, expressed large quantities of 6iHis-UL55 and 6iHis-UL31 fusion proteins.
Generation of polyclonal antisera in rabbits. UL55 and UL31 fusion proteins were electrophoretically separated from E. coli lysates on an SDS-polyacrylamide gel. Gels were then stained with Coomassie brilliant blue, and bands of interest were electroeluted in 0n1 % SDS, 20 mM Tris-HCl (pH 8n0). Male rabbits were immunized first with 0n5 mg of the respective purified fusion protein emulsified in Freund's complete adjuvant. Inoculations were subcutaneous injections on the shaven back. Subsequent boosts used Freund's incomplete adjuvant and 0n5 mg of purified fusion protein. Three booster injections were given each at 3 week intervals after primary injection. Ten days after the last boost, blood was collected from an ear vessel. Both preimmune and immune antisera were extensively adsorbed against acetone powder of E. coli strain BL21(DE3) and uninfected Vero cells prior to use as described by Harlow & Lane (1988) .
Western blotting. Proteins were electrophoretically transferred from SDS-PAGE gels to PVDF transfer membranes as described by Towbin et al. (1979) . Respective bound primary antibodies were detected using horseradish peroxidase-linked sheep anti-rabbit immunoglobulin G (IgG) (Amersham) and ECL Western blotting detection reagents (Amersham).
Indirect immunofluorescence. The indirect immunofluorescence assay was performed essentially as described by Ward et al. (1996 b) . For secondary antibodies, we used fluorescein isothiocyanate (FITC)-conjugated goat anti-rabbit IgG (Sigma) and tetramethylrhodamine isothiocyanate (TRITC)-conjugated goat anti-mouse IgG (Sigma). Fluorescent images were viewed and recorded with the Bio-Rad MRC-series confocal imaging system. Preparation of nuclear matrix. Nuclei and nuclear matrix were isolated as described previously (Tsutsui et al., 1983 ; Yamauchi et al., 1985) . Briefly, infected cells were harvested at 17 h post-infection (p.i.) and washed with PBS three times. Cells were suspended in RSB buffer (10 mM Tris-HCl, 10 mM NaCl, 1n5 mM MgCl # , pH 7n4). After adding 1 % NP40, or 0n5 % NP40j0n5 % deoxycholic acid (DOC), cells were homogenized by ten strokes with a glass homogenizer. The homogenate was layered over 0n5 M sucrose in RSB buffer, and centrifuged at 1500 r.p.m. for 5 min. The nuclear pellet was then washed again with TM sucrose buffer (0n25 M sucrose, 5 mM MgCl # , 50 mM Tris-HCl, pH 7n4). After sedimentation, nuclei were resuspended in TM sucrose buffer, and the purity and morphology of isolated nuclei were examined with a light microscope after staining with 0n1 % toluidine blue. The nuclear fraction was further incubated with 50 µg\ml DNase I for 30 min at room temperature under continuous shaking and washed once in LM buffer (0n2 mM MgCl # , 10 mM Tris-HCl, pH 7n4). The final LM pellet was washed with cold LM buffer three times and then pelleted at 3000 r.p.m. for 15 min (nuclear matrix).
Virion purification. Virus particles were isolated as described by Szila! gyi & Cunningham (1991) .
Results and Discussion Preparation and specificity of anti-UL55 protein antiserum
As a first step toward the study of the UL55 protein, rabbit polyclonal antisera specific to this protein were raised using an E. coli-produced recombinant UL55 fusion protein as antigen. For this purpose the plasmid pET28-UL55 was constructed. When expressed in E. coli, this plasmid expresses the entire UL55 ORF along with a 6iHis tag attached to the N terminus. High levels of the resulting 29 kDa fusion protein were expressed in E. coli following induction by IPTG (Fig. 1 a, lane 2). The induced fusion protein was purified as described in Methods (lane 3).
To examine the reactivity and specificity of UL55 antisera, Western blotting experiments were performed. Vero cells were mock-infected or infected with HSV-2 186, HSV-1 KOS or HSV-1 HF at a multiplicity of 3 p.f.u. per cell. HSV-1 HF has been reported to have a 4 kbp deletion in the BamHI B fragment of the HSV-1 genome (Umene et al., 1984) . Fig. 1 (b) shows that the UL55 antiserum reacted with a band in the HSV-2-and HSV-1-infected cell lysates with an apparent molecular mass of 23 kDa (lanes 3, 4). However, this band was not detected in mock-infected and HSV-1 HF-infected cells (lanes 2, 5). These results indicate that the 23 kDa protein is the product of the HSV-2 UL55 gene. Nucleotide sequence analysis of coding sequences of UL55 predicts a 20 kDa basic protein, and thus the molecular mass of the protein reacted with the UL55 antiserum was consistent with that predicted. The reactivity of this antiserum with the 23 kDa band was clearly eliminated by preadsorption of the antiserum with lysates of E. coli expressing the UL55 fusion protein (lane 7), but there was no significant change in the reactivity after preadsorption with lysates of standard E. coli (lane 6). The preimmune serum did not react with any specific proteins in HSV-2-infected cells (lane 1). Therefore, we used this polyclonal antiserum for further experiments to characterize the UL55 protein of HSV-2. Similarly, we generated rabbit polyclonal antisera to the UL31 protein for use in comparison with the UL55 protein.
The antiserum produced by inoculation of a rabbit with a recombinant 6iHis-UL31 fusion protein specifically reacted with a protein of approximately 34 kDa present in HSV-1 KOS-and HSV-2 186-infected cell lysates (Fig. 1 c, lanes 2, 3) , consistent with the results of Chang & Roizman (1993) . The UL31 antiserum did not react with any proteins present in mock-infected cell lysates (lane 1), nor did the preimmune serum react with any proteins present in either mock-infected or infected cell lysates (data not shown).
Expression of the UL55 protein in infected cells
Expression of the UL55 protein during a lytic HSV-2 replication cycle in infected cells was analysed by determining the accumulation of this protein in HSV-2-infected cells. The temporal class of HSV-2 genes to which the UL55 gene belongs was specified with the following data and experiments with a viral DNA synthesis inhibitor, phosphonoacetic acid (PAA). Vero cells were infected with HSV-2 and extracts of cellular proteins were prepared at the indicated times p.i. As shown in Fig. 2 , the UL55 protein was detected at 10 h p.i. (lane 2), increased in amount and reached its highest level at 15 h p.i. with no appreciable change in the accumulated amount of the protein detected until 25 h p.i. Since the UL55 protein appeared late in infection, it was reasoned that the gene might belong to either γ " or γ # class of HSV genes. To define the temporal class to which the gene belongs, infected cells were maintained in the presence of 300 µg\ml PAA to inhibit viral DNA synthesis. The UL55 protein was not detected in the presence of PAA (Fig. 2, lane 6) , suggesting that UL55 protein was synthesized as a γ # gene. However, it is possible that the amount of the UL55 protein was too low to be detected by Western blotting in the presence of PAA, and thus to define the UL55 gene precisely as a γ # gene, we need to study the kinetics of expression by Northern blotting.
Intracellular localization of the UL55 protein
Two sets of experiments were done to determine the localization of the UL55 protein. In the first, infected cells were fractionated into nuclear and cytoplasmic fractions with 1 % NP40 or with 0n5 % NP40j0n5 % DOC. As shown in Fig. 3 , a large amount of the UL55 protein partitioned with the nuclear fraction (lanes 1, 2). The UL31 protein was not detected in the cytoplasmic fraction. Since the nuclear fractions obtained by NP40 lysis contain the perinuclear filamentous structures (Yamauchi et al., 1985) , DOC was also used to remove the perinuclear structures from the nuclear fractions. Although addition of DOC reduced the amount of the UL55 protein detected in the nuclear fraction, a significant amount of the UL55 protein still partitioned with the nuclear fraction (lanes 3, 4). A small amount of the UL31 protein was detected in the cytoplasmic fraction. Next, the intracellular distribution of UL55 protein in HSV-2-infected cells was analysed by indirect immunofluorescence experiments. As shown in Fig. 4 (c) , the UL55 protein was distributed in bright fluorescent granules within and near the periphery of the nucleus at 17 h p.i. These structures were absent from mock-infected cells (Fig. 4 b) , and no significant fluorescence was observed with the preimmune serum (Fig.  4 a) . In contrast, the UL31 protein was distributed in widespread speckled structures in the nuclei of infected cells (Fig. 4 f) (Chang & Roizman, 1993) . These structures were absent from mock-infected cells (Fig. 4 d) , and no significant fluorescence was observed with the preimmune serum (Fig. 4 e) .
The UL55 protein abutts on the capsid protein ICP35
The immunofluorescent pattern of the UL55 protein in the nucleus was reminiscent of that of capsid proteins (Ward et al., 1996 b) . To determine whether the UL55 protein colocalizes with capsid proteins, Vero cell slide cultures were fixed at 17 h p.i. and double-stained with UL55 antiserum and with mouse monoclonal antibodies to the capsid scaffolding protein ICP35. As shown in Fig. 5 (a-c) the UL55 protein abutted on and partially overlapped the capsid protein ICP35. In cells in which ICP35 did not localize to the discrete peripheral structures, but accumulated in large amounts within the nucleus (Ward et al., 1996 b) , this abutting feature was prominent (d-f ). In contrast, the UL31 protein was distributed throughout the nucleus and appeared to be independent of that of .
It has been demonstrated that capsid proteins ICP35, VP5 and VP19c coalesce at late times p.i. and form antigenically dense structures located within and at the periphery of nuclei close to but not abutting nuclear membranes, and these structures, designated assemblons, are located at the periphery of large globular structures composed of proteins involved in DNA replication (Ward et al., 1996 b) . In addition, UL43.5 and UL16 proteins are reported to colocalize with these capsid proteins (Ward et al., 1996 a ; Nalwanga et al., 1996) . As it is well-known that capsids are composed of seven proteins, VP5, VP19c, VP21, VP22a, VP23, VP24 and VP26 (Tatman et al., 1994 ; Thomsen et al., 1994) , UL43.5 and UL16 proteins are predicted to have an accessory role in capsid assembly or maturation. It has also been reported that the UL15 protein, which is required for packaging of viral DNA into capsids, localizes to DNA replication compartments but not to assemblons (Ward et al., 1996 b) . The distribution pattern of the UL55 protein appeared to be different from those of capsid proteins and proteins involved in DNA replication.
Association of the UL55 protein with the nuclear matrix of infected cells
The distribution of the UL55 protein in the nuclei of infected cells raised the possibility that it was associated with the nuclear matrix fraction. To test this hypothesis, the nucleus of HSV-2-infected cells was fractionated. As shown in Fig. 6 , ICP8 was not detected in the nuclear matrix. In contrast, VP5 was markedly concentrated in the nuclear matrix (Ben-Ze'ev et al., 1983 ; Quinlan & Knipe, 1983) . There were several additional proteins which were associated with the nuclear matrix. The UL55 antiserum reacted with a prominent protein band present predominantly in the nuclear matrix of infected cells (lane 6). Similarly, the UL31 protein was associated with the nuclear matrix (Chang & Roizman, 1993) . However, the UL16 protein was detected exclusively in the supernatant obtained after DNase treatment (lane 4) (Oshima et al., 1998) . As a significant amount of the UL55 protein was found in the cytoplasmic fraction (Fig. 3) , it seems that its association with the nuclear matrix was much weaker than that of the UL31 protein. , 4) , the pellet after DNase I treatment (lanes 2, 5) and the pellet after high salt treatment (nuclear matrix) (lanes 3, 6)., were separated by SDS-PAGE, and the gel was stained with silver. Molecular mass markers (in kDa) are shown to the left (lane M). Identities of VP5 and ICP8 are shown. The same blot was probed with UL55, UL31 and UL16 antisera. Arrowheads indicate UL55, UL31 and UL16 proteins. The nuclear matrix is a proteinaceous nuclear substructure which can be typically prepared by sequential treatment of isolated nuclei with nonionic detergents, nucleases and high salt (Capco et al., 1982) ; it is considered to be the nuclear skeleton which maintains the physical shape and integrity of the nucleus. It has been suggested that the nuclear matrix plays an active role in many molecular processes, such as chromatin organization, DNA replication, gene transcription, RNA splicing and attachment of supercoiled DNA loops (reviewed by Berezney, 1991) . It has been shown by electron microscopy examination that empty capsids are tightly bound to the filamentous networks of the nuclear matrix (Tsutsui et al., 1983) , and that five DNA-binding proteins are present in the nuclear matrix (Pinard et al., 1987) . In addition, UL31 and US10 proteins were recently reported to be associated with the nuclear matrix (Chang & Roizman, 1993 ; Yamada et al., 1997) . However, localization of the three proteins UL31, US10 and UL55 appears to be different. These observations suggest that the nuclear matrix may be involved in various aspects of HSV replication.
The UL55 protein was not detected in virions
The above results suggest that the UL55 protein may be a component of HSV-2 virions. To test this possibility, extracellular virions were purified as described in Methods. The protein composition of each fraction was analysed by SDS-PAGE followed by silver staining (Fig. 7) . By using Ficoll gradient centrifugation, virions can be separated into H and L particles, and L particles are characterized by the absence of the major capsid protein VP5 (Szila! gyi et al., 1991) . The UL55 product was not detected in either H or L particles (lanes 5, 6). Similarly, the UL31 protein was not detected in both H and L particles (Blaho et al., 1994) . Although we cannot exclude the possibility that an amount of it too small to be detected is packaged in virions, these results indicated that the UL55 protein is not a stable component of HSV-2 virions.
Our present study suggests that the UL55 protein may play an accessory role in virion assembly or maturation, but the functional mechanism and nature of the association with capsid proteins and the nuclear matrix remain to be determined.
